PrecisionLife & Ovation are bringing precision medicine to GLP-1s - with new genetic markers predicting response and tests launching in 2026.
This creates a significant opportunity to improve outcomes for patients, payors, providers, and pharma.
Learn more here: precisionlife.com/news-and-eve...
